Modification of drug-binding proteins associated with the efflux pump in MDR-MTB in course of evolution: an unraveled clue based on in silico approach.

The Journal of Antibiotics
Anindya Sundar PanjaRajib Bandopadhyay

Abstract

Mycobacterium tuberculosis (MTB) is commonly resistant to various drugs. Multidrug-resistant tuberculosis (MDR-MTB) is mostly caused by mutation in drug-binding proteins and protein folding. The aim of the study was to identify the pattern of mutations in embC, inhA and rpoB proteins and investigate its interactions with available drug such as rifampicin, ethambutol and isoniazid, using a computer docking method. The evolution of drugs resistant mechanisms of MTB was analyzed using an in silico approach. The model proteins were considered to be in a protein-protein interaction network among the twenty transmembrane proteins. The changes in structural conformation may describe the significance of the proton pumps system. The docking analysis revealed that unlike isoniazid, both rifampicin and ethambutol, bound to the same residues in mutant and wild forms. Moreover, multiple-sequence alignment (MSA) showed mutational hotspot regions where the substitution of amino acids in these three target proteins was position specific under stress. The molecular basis of drug resistance in M. tuberculosis can be represented by a protein network which is a well-regulated system for efflux pump activation by popularly used drugs. Ethambutol an...Continue Reading

References

Jan 1, 1967·Biochimica Et Biophysica Acta·G HartmannJ Nüesch
Jan 18, 1995·JAMA : the Journal of the American Medical Association·M C RaviglioneA Kochi
Mar 1, 1997·Clinics in Chest Medicine·A Telenti
Jul 8, 2000·Microbes and Infection·R A Slayden, C E Barry
Sep 9, 2000·FEMS Microbiology Reviews·M BraibantJ Content
Dec 20, 2000·Antimicrobial Agents and Chemotherapy·B Vester, S Douthwaite
Aug 30, 2001·Journal of Clinical Microbiology·K J EdwardsN A Saunders
Nov 1, 1962·Journal of Bacteriology·M FORBESE A PEETS
Jan 18, 2005·Clinical Microbiology Reviews·Kuni TakayamaGurdyal S Besra
Sep 20, 2008·PLoS Pathogens·Thierry WirthStefan Niemann
Apr 29, 2009·Journal of Computational Chemistry·Garrett M MorrisArthur J Olson
Feb 5, 2015·The Journal of Antibiotics·Irene IsclaRamiz A Boulos

❮ Previous
Next ❯

Software Mentioned

Discovery Studio
String
RasMol
Autodock
MSA
Clustal Omega
PyMOL

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.